# Ondansetron

NDC: 68071-2763
Generic name: Ondansetron
Labeler / Manufacturer: NuCare Pharmaceuticals,Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20210427

FDA application: ANDA090469

## Active ingredients

- ONDANSETRON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68071-2763"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68071-2763
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e183c59c-2a7c-dba3-e053-2a95a90acf87